Century Therapeutics - IPSC Revenue Dynamics YoY (Last Twelve Months)

Century Therapeutics creates universal cell products for mass cancer therapy. The YoY revenue growth rate for the trailing 12-month period on the GURU.Markets chart reflects the business dynamics, where the current value is -99.80. Balance sheet liquidity is supported by advances from pharma behemoths, however, pricing power will only emerge after FDA approval, while the company currently relies on external financing.
Century Therapeutics, Inc. (IPSC) - metric breakdowns and financial figures

Century Therapeutics is scaling innovative iPSC therapy, creating affordable, universal cellular solutions to combat cancer. An analysis of the 12-month rolling sales growth versus the previous year allows for tracking the commercialization pace of these developments. This metric measures the percentage change in revenue over the last year, neutralizing seasonality and reflecting the actual growth trend. However, the rapid surge in revenue requires a comparison with operating profit to eliminate the risk of asset overvaluation due to excessive marketing expenditures.